🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2016 | 49,47 | 50,51 | 49,38 | 50,23 | +1,08% | 2,28% | 7.824.682 |
| 04/03/2016 | 49,48 | 49,90 | 49,14 | 49,69 | -0,04% | 1,52% | 9.521.918 |
| 03/03/2016 | 49,79 | 49,92 | 48,81 | 49,71 | -0,33% | 2,24% | 10.279.622 |
| 02/03/2016 | 49,27 | 50,04 | 49,16 | 49,88 | +1,00% | 1,78% | 12.548.857 |
| 01/03/2016 | 48,08 | 49,56 | 47,80 | 49,38 | +3,07% | 3,67% | 12.686.774 |
| 29/02/2016 | 48,21 | 48,50 | 47,85 | 47,91 | -0,85% | 1,35% | 13.507.358 |
| 26/02/2016 | 48,71 | 48,79 | 48,31 | 48,32 | -0,71% | 0,98% | 9.695.362 |
| 25/02/2016 | 48,24 | 48,66 | 48,08 | 48,66 | +0,87% | 1,21% | 9.110.998 |
| 24/02/2016 | 47,86 | 48,30 | 47,36 | 48,24 | +0,04% | 1,97% | 7.936.190 |
| 23/02/2016 | 48,24 | 48,61 | 48,12 | 48,23 | -0,45% | 1,01% | 8.278.676 |
| 22/02/2016 | 47,98 | 48,45 | 47,83 | 48,44 | +1,30% | 1,29% | 8.143.274 |
| 19/02/2016 | 47,95 | 48,09 | 47,59 | 47,82 | -0,40% | 1,05% | 9.394.482 |
| 18/02/2016 | 48,28 | 48,65 | 47,95 | 48,02 | -0,55% | 1,46% | 10.074.319 |
| 17/02/2016 | 47,71 | 48,33 | 47,67 | 48,28 | +1,65% | 1,38% | 9.770.818 |
| 16/02/2016 | 47,14 | 47,70 | 46,98 | 47,50 | +1,53% | 1,52% | 11.964.178 |
| 12/02/2016 | 46,74 | 46,86 | 46,07 | 46,78 | +0,37% | 1,69% | 14.251.018 |
| 11/02/2016 | 46,57 | 47,13 | 46,29 | 46,61 | -1,37% | 1,80% | 11.620.643 |
| 10/02/2016 | 47,24 | 48,10 | 47,22 | 47,26 | +0,75% | 1,86% | 11.565.833 |
| 09/02/2016 | 46,46 | 47,30 | 46,18 | 46,91 | +0,68% | 2,40% | 11.160.257 |
| 08/02/2016 | 46,69 | 47,07 | 45,77 | 46,59 | -1,11% | 2,78% | 13.985.665 |
| 05/02/2016 | 46,37 | 47,44 | 46,06 | 47,12 | +1,63% | 2,98% | 17.693.384 |
| 04/02/2016 | 47,42 | 47,46 | 45,83 | 46,36 | -2,92% | 3,44% | 21.598.442 |
| 03/02/2016 | 47,35 | 47,81 | 46,36 | 47,76 | -0,71% | 3,08% | 20.507.893 |
| 02/02/2016 | 47,97 | 48,20 | 47,61 | 48,10 | -0,67% | 1,21% | 15.614.466 |
| 01/02/2016 | 48,08 | 48,65 | 47,56 | 48,43 | +0,16% | 2,26% | 11.979.898 |
| 29/01/2016 | 47,52 | 48,35 | 47,31 | 48,35 | +2,99% | 2,19% | 17.734.990 |
| 28/01/2016 | 48,02 | 48,23 | 46,74 | 46,95 | -2,32% | 3,10% | 18.996.991 |
| 27/01/2016 | 48,34 | 49,21 | 47,55 | 48,06 | -2,10% | 3,43% | 13.748.817 |
| 26/01/2016 | 48,71 | 49,24 | 48,44 | 49,09 | +1,04% | 1,65% | 9.450.340 |
| 25/01/2016 | 49,00 | 49,08 | 48,44 | 48,59 | -0,84% | 1,32% | 9.725.964 |